Charles Schwab’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $545M | Sell |
|
|||||
|
2025
Q2 | $702M | Buy |
|
|||||
|
2025
Q1 | $775M | Buy |
|
|||||
|
2024
Q4 | $617M | Buy |
|
|||||
|
2024
Q3 | $838M | Buy |
|
|||||
|
2024
Q2 | $864M | Buy |
|
|||||
|
2024
Q1 | $812M | Buy |
|
|||||
|
2023
Q4 | $721M | Buy |
|
|||||
|
2023
Q3 | $644M | Buy |
|
|||||
|
2023
Q2 | $653M | Buy |
|
|||||
|
2023
Q1 | $674M | Buy |
|
|||||
|
2022
Q4 | $741M | Buy |
|
|||||
|
2022
Q3 | $644M | Buy |
|
|||||
|
2022
Q2 | $639M | Sell |
|
|||||
|
2022
Q1 | $655M | Buy |
|
|||||
|
2021
Q4 | $600M | Sell |
|
|||||
|
2021
Q3 | $485M | Buy |
|
|||||
|
2021
Q2 | $485M | Buy |
|
|||||
|
2021
Q1 | $449M | Sell |
|
|||||
|
2020
Q4 | $406M | Buy |
|
|||||
|
2020
Q3 | $337M | Sell |
|
|||||
|
2020
Q2 | $359M | Sell |
|
|||||
|
2020
Q1 | $311M | Buy |
|
|||||
|
2019
Q4 | $407M | Buy |
|
|||||
|
2019
Q3 | $318M | Buy |
|
|||||
|
2019
Q2 | $366M | Buy |
|
|||||
|
2019
Q1 | $347M | Buy |
|
|||||
|
2018
Q4 | $315M | Buy |
|
|||||
|
2018
Q3 | $326M | Buy |
|
|||||
|
2018
Q2 | $276M | Buy |
|
|||||
|
2018
Q1 | $252M | Buy |
|
|||||
|
2017
Q4 | $246M | Buy |
|
|||||
|
2017
Q3 | $199M | Sell |
|
|||||
|
2017
Q2 | $198M | Buy |
|
|||||
|
2017
Q1 | $169M | Buy |
|
|||||
|
2016
Q4 | $139M | Buy |
|
|||||
|
2016
Q3 | $116M | Buy |
|
|||||
|
2016
Q2 | $118M | Buy |
|
|||||
|
2016
Q1 | $121M | Buy |
|
|||||
|
2015
Q4 | $119M | Buy |
|
|||||
|
2015
Q3 | $117M | Sell |
|
|||||
|
2015
Q2 | $141M | Sell |
|
|||||
|
2015
Q1 | $133M | Buy |
|
|||||
|
2014
Q4 | $105M | Buy |
|
|||||
|
2014
Q3 | $98.2M | Sell |
|
|||||
|
2014
Q2 | $88.6M | Sell |
|
|||||
|
2014
Q1 | $82.1M | Sell |
|
|||||
|
2013
Q4 | $92M | Sell |
|
|||||
|
2013
Q3 | $97.9M | Buy |
|
|||||
|
2013
Q2 | $92.3M | Buy |
|